Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Schedule of Reconciliation of Net Loss to Net Loss Attributable to Heat Biologics, Inc.) (Details)

v3.7.0.1
Net Loss Per Share (Schedule of Reconciliation of Net Loss to Net Loss Attributable to Heat Biologics, Inc.) (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Earnings Per Share [Abstract]        
Net loss $ (3,309,081) $ (3,032,767) $ (6,549,809) $ (7,767,253)
Net loss: Non-controlling interest (90,166) (107,546) (140,956) (282,428)
Net loss attributable to Heat Biologics, Inc. $ (3,218,915) $ (2,925,221) $ (6,408,853) $ (7,484,825)
Weighted-average number of common shares used in net loss per share attributable to Heat Biologics, Inc. - basic and diluted 35,244,833 17,524,641 31,124,119 13,324,641
Net loss per share attributable to Heat Biologics, Inc. - basic and diluted $ (0.09) $ (0.17) $ (0.21) $ (0.56)